Equid herpesvirus 4 (ATCC® VR-2230)

Classification: Herpesviridae, Varicellovirus  /  Product Format: frozen 1 mL per vial

Permits and Restrictions

View Permits

Classification Herpesviridae, Varicellovirus
Agent Equid herpesvirus 4
Strain 405/76
Common Name Equine herpesvirus 4
Biosafety Level 2
Product Format frozen 1 mL per vial
Storage Conditions  -70°C or colder
Comments
Endemic to horses in the United States.
Effect on Host
 CPE
CPE
Recommended Host

Production Host:  BS-C-1 (ATCC® CCL-26)

BS-C-1 (ATCC CCL-26)
Growth Conditions
Temperature: 37°C
Incubation: 1-2 days
Effect on Host
 CPE
CPE
Name of Depositor MJ Studdert, The University of Melbourne
Special Collection ATCC
Source
Aborted equine fetus, Australia
References

Studdert MJ. Vaccine for equine herpesvirus. U.S. Patent 5,084,271 dated January 28 1992.

Fitzpatrick DR, Studdert MJ. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus). Am. J. Vet. Res. 45: 1947-1952, 1984. PubMed: 6208822

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
  • USDA APHIS VS 16-6 or 16-6A permit must be obtained and a copy of the permit must be sent to ATCC in advance of shipment. The Application Form VS 16-3 (Import controlled material import or transport organisms or vectors) must be submitted to USDA APHIS Veterinary Services to obtain the VS 16-6 or 16-6A permit.
Basic Documentation